Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ By Ogkologos - January 8, 2025 811 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the COMET study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Joins WHO Global Clinical Trials Forum to Strengthen Global Oncology Research Ecosystems EMA Recommends Extension of Therapeutic Indications for Enfortumab Vedotin Selinexor plus Ruxolitinib Reduces Spleen Volume, but Does Not Improve Symptom Responses Over Ruxolitinib in Patients with JAK Inhibitor-Naïve Myelofibrosis MOST POPULAR Hundreds Of Thousands Of Peruvian Women Were Forcibly Sterilized, And Now... October 29, 2021 After a Generous Donor Covered Her Bills, Breast Cancer Survivor Raises... December 22, 2020 Opinion: “We’ve been pushing for change for 20 years. We’re not... January 24, 2022 The Most Successful Female Singer Of The 1970s Disappeared. Now She’s... May 1, 2019 Load more HOT NEWS Safety, Tolerability and Antitumour Activity of Lorlatinib in Patients with ALK-Driven... Post-Mastectomy Boutique Set to Close After 12 Years, As Owner Has... Adding One Year of Palbociclib to Adjuvant Endocrine Treatment Does Not... 9 Ways To Teach Kids To Be Confident (Without Teaching Them...
